APP and Alzheimer disease: Familial AD, which affects fewer than 5% of patients, results from mutations in specific genes that alter the amyloid precursor protein (APP) or presenilin-1 and -2 (PS1/PS2) (Xiao et al., 2021; Lanoiselée et al., 2017).